Last update :
28/04/2024
Glucose-lowering   Insulin glulisine  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Apidra Austria, Belgium, Brazil, Canada, Chile, Colombia, Denmark, Ecuador, Egypt, Finland, France, Germany, Great Britain, Greece, Hungary, Iceland, Ireland, Italy, Japan, Luxembourg, Morocco, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, United States of America
Shorant Mexico
Stability of mixtures   Injection   Stability of mixtures : Insulin glulisine     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Polyolefine Sodium chloride 0,9% 1 U/ml
Injection   Insulin glulisine   
Injection   Potassium chloride 0.04 mEq/l
25°C
48 Hour
Not specified 3935
Manufacturer's stability data

  Mentions Légales